Catalogo Articoli (Spogli Riviste)

HELP
ATTENZIONE: attualmente gli articoli Current Contents (fonte ISI) a partire dall'anno 2002 sono consultabili sulla Risorsa On-Line

Le informazioni sugli articoli di fonte ISI sono coperte da copyright

La ricerca find articoli where authors phrase all words ' Potkin, SG' sort by level,fasc_key/DESCEND, pagina_ini_num/ASCEND ha restituito 86 riferimenti
Selezionare un intervallo

Per ulteriori informazioni selezionare i riferimenti di interesse.

    1. Potkin, SG; Anand, R; Fleming, K; Alva, G; Keator, D; Carreon, D; Messina, J; Wu, JC; Hartman, R; Fallon, JH
      Brain metabolic and clinical effects of rivastigmine in Alzheimer's disease

      INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY
    2. Basile, VS; Ozdemir, V; Masellis, M; Meltzer, HY; Lieberman, JA; Potkin, SG; Macciardi, FM; Petronis, A; Kennedy, JL
      Lack of association between serotonin-2A receptor gene (HTR2A) polymorphisms and tardive dyskinesia in schizophrenia

      MOLECULAR PSYCHIATRY
    3. Cahill, L; Haier, RJ; White, NS; Fallon, J; Kilpatrick, L; Lawrence, C; Potkin, SG; Alkire, MT
      Sex-related difference in amygdala activity during emotionally influenced memory storage

      NEUROBIOLOGY OF LEARNING AND MEMORY
    4. Kojima, T; Matsushima, E; Ohta, K; Toru, M; Han, YH; Shen, YC; Moussaoui, D; David, I; Sato, K; Yamashita, I; Kathmann, N; Hippius, H; Thavundayil, JX; Lal, S; Nair, NPV; Potkin, SG; Prilipko, L
      Stability of exploratory eye movements as a marker of schizophrenia - a WHO multi-center study

      SCHIZOPHRENIA RESEARCH
    5. Potkin, SG; Fleming, K; Jin, Y; Gulasekaram, B
      Clozapine enhances neurocognition and clinical symptomatology more than standard neuroleptics

      JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY
    6. Fleming, K; Thyrum, P; Yeh, C; Vargo, DL; Potkin, SG
      Cognitive improvements in psychotic subjects treated with "Seroquel" (quetiapine fumarate): An exploratory study

      JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY
    7. Asnis, GM; Hameedi, FA; Goddard, AW; Potkin, SG; Black, D; Jameel, M; Desagani, K; Woods, SW
      Fluvoxamine in the treatment of panic disorder: a multi-center, double-blind, placebo-controlled study in outpatients

      PSYCHIATRY RESEARCH
    8. Daniel, DG; Potkin, SG; Reeves, KR; Swift, RH; Harrigan, EP
      Intramuscular (IM) ziprasidone 20 mg is effective in reducing acute agitation associated with psychosis: a double-blind, randomized trial

      PSYCHOPHARMACOLOGY
    9. Basile, VS; Ozdemir, V; Masellis, M; Walker, ML; Heltzer, HY; Lieberman, JA; Potkin, SG; Alva, G; Kalow, W; Macciardi, FM; Kennedy, JL
      A functional polymorphism of the cytochrome P450 1A2 (CYP1A2) gene: association with tardive dyskinesia in schizophrenia

      MOLECULAR PSYCHIATRY
    10. Moayeri, SE; Cahill, L; Jin, Y; Potkin, SG
      Relative sparing of emotionally influenced memory in Alzheimer's disease

      NEUROREPORT
    11. Jin, Y; Castellanos, A; Solis, ER; Potkin, SG
      EEG resonant responses in schizophrenia: a photic driving study with improved harmonic resolution

      SCHIZOPHRENIA RESEARCH
    12. Popken, GJ; Bunney, WE; Potkin, SG; Jones, EG
      Subnucleus-specific loss of neurons in medial thalamus of schizophrenics

      PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
    13. Vincent, JB; Neves-Pereira, ML; Paterson, AD; Yamamoto, E; Parikh, SV; Macciardi, F; Gurling, HMD; Potkin, SG; Pato, CN; Macedo, A; Kovacs, M; Davies, M; Lieberman, JA; Meltzer, HY; Petronis, A; Kennedy, JL
      An unstable trinucleotide-repeat region on chromosome 13 implicated in spinocerebellar ataxia: A common expansion lotus

      AMERICAN JOURNAL OF HUMAN GENETICS
    14. Basile, VS; Masellis, M; Badri, F; Paterson, AD; Meltzer, HY; Lieberman, JA; Potkin, SG; Macciardi, F; Kennedy, JL
      Association of the MscI polymorphism of the dopamine D3 receptor gene withtardive dyskinesia in schizophrenia

      NEUROPSYCHOPHARMACOLOGY
    15. Daniel, DG; Zimbroff, DL; Potkin, SG; Reeves, KR; Harrigan, EP; Lakshminarayanan, M
      Ziprasidone 80 mg/day and 160 mg/day in the acute exacerbation of schizophrenia and schizoaffective disorder: A 6-week placebo-controlled trial

      NEUROPSYCHOPHARMACOLOGY
    16. Bunney, WE; Hetrick, WP; Bunney, BG; Patterson, JV; Jin, Y; Potkin, SG; Sandman, CA
      Structured interview for assessing perceptual anomalies (SIAPA)

      SCHIZOPHRENIA BULLETIN
    17. Potkin, SG; Jin, Y; Bunney, BG; Costa, J; Gulasekaram, B
      Effect of clozapine and adjunctive high-dose glycine in treatment-resistant schizophrenia

      AMERICAN JOURNAL OF PSYCHIATRY
    18. POTKIN SG; KENNEDY J; BADRI F; JIN Y; MASELLIS M; KEATOR DB; FROST J; WU JC; NAJAFI A
      A GENETIC PET SCAN STUDY - D1 ALLELES PREDICT CLINICAL-RESPONSE TO CLOZAPINE AND CORRESPONDING BRAIN METABOLISM

      American journal of medical genetics
    19. BAYSAL BE; POTKIN SG; FARR JE; HIGGINS MJ; KORCZ J; GOLLIN SM; JAMES MR; EVANS GA; RICHARD CW
      BIPOLAR AFFECTIVE-DISORDER PARTIALLY COSEGREGATES WITH A BALANCED T(9-11)(P24-Q23.1) CHROMOSOMAL TRANSLOCATION IN A SMALL PEDIGREE

      American journal of medical genetics
    20. Huntsman, MM; Tran, BV; Potkin, SG; Bunney, WE; Jones, EG
      Altered ratios of alternatively spliced long and short gamma 2 subunit mRNAs of the gamma-amino butyrate type A receptor in prefrontal cortex of schizophrenics

      PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
    21. JIN Y; POTKIN SG; SANDMAN CA; BUNNEY WE
      TOPOGRAPHIC ANALYSIS OF EEG PHOTIC DRIVING IN PATIENTS WITH SCHIZOPHRENIA FOLLOWING CLOZAPINE TREATMENT

      Clinical EEG electroencephalography
    22. JIN Y; BUNNEY WE; SANDMAN CA; PATTERSON JV; FLEMING K; MOENTER JR; KALALI AH; HETRICK WP; POTKIN SG
      IS P50 SUPPRESSION A MEASURE OF SENSORY GATING IN SCHIZOPHRENIA

      Biological psychiatry
    23. POTKIN SG; KENNEDY J; BADRI F; JIN Y; MASELLIS M; GULASEKARAM B; COSTA J; KEATOR DB; TELFORD J; WU JC; NAJAFI A
      D1 ALLELES PREDICT CLINICAL-RESPONSE TO CLOZAPINE AND CORRESPONDING BRAIN METABOLISM - A GENETIC PET SCAN STUDY

      Schizophrenia research
    24. FLEMING K; NIELSON K; NILSSON M; KALALI A; SANDMAN C; POTKIN SG; BUNNEY W
      LONGITUDINAL ASSESSMENT OF NEUROPSYCHIATRIC FUNCTIONING IN PATIENTS WITH SCHIZOPHRENIA AND ALZHEIMERS-DISEASE

      Schizophrenia research
    25. POTKIN SG; JIN Y; BUNNEY B; GULASEKARAM B; COSTA J; KEATOR DB; TELFORD J; WU JC; NAJAFI A; BUNNEY WE
      CLINICAL AND BRAIN IMAGING EFFECTS OF ADJUNCTIVE HIGH-DOSE GLYCINE WITH CLOZAPINE IN SCHIZOPHRENIA

      Schizophrenia research
    26. POTKIN SG; FLEMING K; TELFORD J; COSTA J; GULASEKARAM B; JIN Y
      CLOZAPINE ENHANCES NEUROCOGNITION AND CLINICAL SYMPTOMS MORE THAN STANDARD NEUROLEPTICS

      Schizophrenia research
    27. FLEMING K; KALALI A; YEH C; VARGO DL; THYRUM PT; POTKIN SG
      THE NEUROCOGNITIVE EFFECTS OF QUETIAPINE (SEROQUEL, ICI-204,636)

      Schizophrenia research
    28. KALALI AH; POTKIN SG
      PATIENTS SATISFACTION WITH AND ACCEPTABILITY OF SEROQUEL

      Schizophrenia research
    29. POTKIN SG; THYRUM PT; BERA R; VARGO D; CARREON D; KALALI A; MAGUIRE G; YEH C; EWING BJ; WONG YWJ
      PHARMACOKINETICS AND SAFETY OF LITHIUM CO-ADMINISTERED WITH SEROQUEL (QUETIAPINE)

      Schizophrenia research
    30. FLEMING K; MOSKO OA; VOVAN B; CHEN E; JIN Y; POTKIN SG
      ELECTROPHYSIOLOGY OF DIFFERENTIAL COGNITIVE LOAD - AN EEG STUDY EXAMINING THE FRONTAL-CORTEX

      Schizophrenia research
    31. JIN Y; POTKIN SG; SANDMAN C; BUNNEY WE
      SINGLE-DOSE CHALLENGE PREDICTS CLINICAL-RESPONSE TO CLOZAPINE - A PHARMACO-EEG STUDY

      Schizophrenia research
    32. JIN Y; BUNNEY WE; HETRICK WP; SANDMAN C; PATERON J; POTKIN SG
      P50 AND EXPERIENCE OF HYPERSENSITIVITY TO EXTERNAL STIMULI

      Schizophrenia research
    33. KALALI AH; FRANKLIN D; CARREON D; POTKIN SG
      PREVALENCE OF EXTRAPYRAMIDAL SYMPTOMS IN PATIENTS TREATED CONCURRENTLY WITH LITHIUM AND SEROQUEL

      Schizophrenia research
    34. POTKIN SG; OLDROYD J; JIN Y; GULASEKARAM B; COSTA J; TELFORD J
      SUPERSENSITIVITY PSYCHOSIS FOLLOWING CLOZAPINE DISCONTINUATION - MYTHOR REALITY

      Schizophrenia research
    35. JIN Y; POTKIN SG; PATTERSON JV; SANDMAN CA; HETRICK WP; BUNNEY WE
      EFFECTS OF P50 TEMPORAL VARIABILITY ON SENSORY GATING IN SCHIZOPHRENIA

      Psychiatry research
    36. SALVATORE M; MORZUNOV S; SCHWEMMLE M; LIPKIN WI; BUNNEY WE; COTMAN CW; EVEN C; HATALSKI CG; POTKIN SG; PORTLANCE ML; NICHOL ST; TOURTELLOUTTE WW; RIEDERER P; TERMEULEN V
      BORNA-DISEASE VIRUS IN BRAINS OF NORTH-AMERICAN AND EUROPEAN PEOPLE WITH SCHIZOPHRENIA AND BIPOLAR DISORDER

      Lancet
    37. HONG CCH; POTKIN SG; ANTROBUS JS; DOW BM; CALLAGHAN GM; GILLIN JC
      REM-SLEEP EYE-MOVEMENT COUNTS CORRELATE WITH VISUAL-IMAGERY IN DREAMING - A PILOT-STUDY

      Psychophysiology
    38. WONG YWJ; EWING BJ; THYRUM PT; YEH C; POTKIN SG
      EFFECTS OF HALOPERIDOL, RISPERIDONE, AND THIORIDAZINE ON THE PHARMACOKINETICS OF QUETIAPINE

      Psychopharmacology bulletin
    39. WIGAL SB; SWANSON JM; POTKIN SG
      LATERALIZED ATTENTIONAL DEFICITS IN DRUG-FREE AND MEDICATED SCHIZOPHRENIC-PATIENTS

      Neuropsychologia
    40. BUNNEY BG; POTKIN SG; BUNNEY WE
      NEUROPATHOLOGICAL STUDIES OF BRAIN-TISSUE IN SCHIZOPHRENIA

      Journal of Psychiatric Research
    41. JIN Y; POTKIN SG; SANDMAN CA; BUNNEY WE
      ELECTROENCEPHALOGRAPHIC PHOTIC DRIVING IN PATIENTS WITH SCHIZOPHRENIAAND DEPRESSION

      Biological psychiatry
    42. JIN Y; CHEN E; MAGUIRE G; ENDO L; POTKIN SG
      EEG PHOTIC DRIVING IN ALZHEIMERS-DISEASE

      Biological psychiatry
    43. KALALI AH; FRANKLIN D; CARREON D; POTKIN SG
      ADDING SEROQUEL TO LITHIUM DOES NOT INCREASE EXTRAPYRAMIDAL EFFECTS

      Biological psychiatry
    44. WIGAL T; WIGAL SB; CAVOTO KF; SWANSON JM; CHRISTIAN DL; CLEVENGER W; CRINELLA FM; POTKIN SG; CARREON DT; SPRAGUE RL
      STANDARDIZED VIDEOTAPED PROCEDURE FOR EVALUATING WITHDRAWAL-EMERGENT TARDIVE-DYSKINESIA IN A PUBLIC RESIDENTIAL FACILITY

      Journal of developmental and physical disabilities
    45. SCHRODER J; BUCHSBAUM MS; SIEGEL BV; GEIDER FJ; LOHR J; TANG C; WU J; POTKIN SG
      CEREBRAL METABOLIC-ACTIVITY CORRELATES OF SUBSYNDROMES IN CHRONIC-SCHIZOPHRENIA

      Schizophrenia research
    46. BEASLEY CM; TOLLEFSON G; TRAN P; SATTERLEE W; SANGER T; HAMILTON S; FABRE L; SMALL J; ERESHEFSKY L; TRUE J; NEMEROFF C; RISCH SC; PERRY PJ; POTKIN SG; BORISON RL; JAMES S; MELTZER HY; IQBAL N; FANN WE; GEWIRTZ GR; LANDBLOOM R; ROYBYRNE PP; TUASON VB; CARMAN JS; STOKES PE; WILLIAMS R; ANCILL RJ; MACEWAN GW; GUJAVARTY KS; JONES B; LOHR JB
      OLANZAPINE VERSUS PLACEBO AND HALOPERIDOL - ACUTE-PHASE RESULTS OF THE NORTH-AMERICAN DOUBLE-BLIND OLANZAPINE TRIAL

      Neuropsychopharmacology
    47. AKBARIAN S; SUCHER NJ; BRADLEY D; TAFAZZOLI A; TRINH D; HETRICK WP; POTKIN SG; SANDMAN CA; BUNNEY WE; JONES EG
      SELECTIVE ALTERATIONS IN GENE-EXPRESSION FOR NMDA RECEPTOR SUBUNITS IN PREFRONTAL CORTEX OF SCHIZOPHRENICS

      The Journal of neuroscience
    48. HONG CCH; JIN Y; POTKIN SG; BUCHSBAUM MS; WU J; CALLAGHAN GM; NUDLEMAN KL; GILLIN JC
      LANGUAGE IN DREAMING AND REGIONAL EEG ALPHA-POWER

      Sleep
    49. POTKIN SG; ZBOROWSKI J; WU J; MACK R; AURANG C; SEBREE T; CARREON D; BERA R
      BRAIN IMAGING TO DETERMINE THE EFFECTS OF SERTINDOLE IN SCHIZOPHRENIC-PATIENTS

      Psychopharmacology bulletin
    50. HELMESTE DM; TANG SW; BUNNEY WE; POTKIN SG; JONES EG
      DECREASE IN SIGMA BUT NO INCREASE IN STRIATAL DOPAMINE D-4 SITES IN SCHIZOPHRENIC BRAINS

      European journal of pharmacology
    51. JIN Y; POTKIN SG
      P50 CHANGES WITH VISUAL INTERFERENCE IN NORMAL SUBJECTS - A SENSORY DISTRACTION MODEL FOR SCHIZOPHRENIA

      Clinical EEG electroencephalography
    52. BERA R; KALALI AH; GULASEKARAM B; HAYES S; JIN Y; COSTA J; OLDROYD J; COOPER T; POTKIN SG
      PREDICTING CLINICAL-RESPONSE TO CLOZAPINE TREATMENT BY PLASMA-LEVEL

      Biological psychiatry
    53. KALALI AH; BERA R; GULASEKARAM B; HAYES S; JIN Y; COSTA J; OLDROYD J; COOPER T; POTKIN SG
      THE RELATIONSHIP BETWEEN CLOZAPINE DOSE AND PLASMA-LEVEL AND SIDE-EFFECTS

      Biological psychiatry
    54. POTKIN SG; WU JC; KLEIN EA; KHOSLA N; NAJAFI A; LACASSE L
      FDOPA UPTAKE IN SCHIZOPHRENIA - A PET STUDY

      Biological psychiatry
    55. JIN Y; POTKIN SG; CEZAR C
      EEG RESONANT RESPONSES TO PHOTIC-STIMULATION FOLLOWING SDZ MAR-327 TREATMENT

      Biological psychiatry
    56. HETRICK WP; SANDMAN CA; BUNNEY WE; JIN Y; POTKIN SG; WHITE MH
      GENDER DIFFERENCES IN GATING OF THE AUDITORY-EVOKED POTENTIAL IN NORMAL SUBJECTS

      Biological psychiatry
    57. AKBARIAN S; KIM JJ; POTKIN SG; HETRICK WP; BUNNEY WE; JONES EG
      MALDISTRIBUTION OF INTERSTITIAL NEURONS IN PREFRONTAL WHITE-MATTER OFTHE BRAINS OF SCHIZOPHRENIC-PATIENTS

      Archives of general psychiatry
    58. BUNNEY BG; POTKIN SG; BUNNEY WE
      NEW MORPHOLOGICAL AND NEUROPATHOLOGICAL FINDINGS IN SCHIZOPHRENIA - ANEURODEVELOPMENTAL PERSPECTIVE

      Clinical neuroscience
    59. AKBARIAN S; HUNTSMAN MM; KIM JJ; TAFAZZOLI A; POTKIN SG; BUNNEY WE; JONES EG
      GABA(A) RECEPTOR SUBUNIT GENE-EXPRESSION IN HUMAN PREFRONTAL CORTEX -COMPARISON OF SCHIZOPHRENICS AND CONTROLS

      Cerebral cortex
    60. NILSSON MN; BUNNEY WE; POTKIN SG; SANDMAN C
      COGNITIVE DECLINE IN SCHIZOPHRENIC-PATIENTS AND NORMAL CONTROL FOLLOWED LONG-TERM

      Schizophrenia research
    61. JIN Y; SANDMAN C; POTKIN SG; WU JC; HETRICK W; PATTERSON J; BUNNEY WE
      REEVALUATION OF SENSORY GATING IN NORMAL AND SCHIZOPHRENIC SUBJECTS

      Schizophrenia research
    62. JIN Y; POTKIN SG; WU JC; TELFORD J; SANDMAN C
      CLOZAPINE EFFECTS ON TOPOGRAPHIC EEG PHOTIC DRIVING

      Schizophrenia research
    63. JIN Y; POTKIN SG; SANDMAN C
      CLOZAPINE INCREASES EEG PHOTIC DRIVING IN CLINICAL RESPONDERS

      Schizophrenia bulletin
    64. JIN Y; SANDMAN CA; WU JC; BERNAT J; POTKIN SG
      TOPOGRAPHIC ANALYSIS OF EEG PHOTIC DRIVING IN NORMAL AND SCHIZOPHRENIC SUBJECTS

      Clinical EEG electroencephalography
    65. MOAYERI SE; POTKIN SG; JIN Y
      SELECTIVE ATTENTION IN SCHIZOPHRENICS MEASURED BY A MODIFIED LABERGE TASK

      Biological psychiatry
    66. JIN Y; POTKIN SG; WU JC; TELFORD J; SANDMAN C
      TOPOGRAPHIC CHANGE IN EEG PHOTIC DRIVING FOLLOWING CLOZAPINE

      Biological psychiatry
    67. JIN Y; PHAM J; MOAYERI SE; TELFORD J; POTKIN SG
      CHANGES IN EEG RESONANCE FOLLOWING SDZ MAR-327 TREATMENT

      Biological psychiatry
    68. AKBARIAN S; KIM JJ; POTKIN SG; HAGMAN JO; TAFAZZOLI A; BUNNEY WE; JONES EG
      GENE-EXPRESSION FOR GLUTAMIC-ACID DECARBOXYLASE IS REDUCED WITHOUT LOSS OF NEURONS IN PREFRONTAL CORTEX OF SCHIZOPHRENICS

      Archives of general psychiatry
    69. BAYSAL BE; POTKIN SG; FARR JE; HIGGINS MJ; GOLLIN SM; SMITH M; JAMES MR; RICHARD CW
      CLONING A BALANCED T(9-11)(P24-Q23.1) CHROMOSOMAL TRANSLOCATION BREAKPOINT SEGREGATING WITH BIPOLAR AFFECTIVE-DISORDER IN A SMALL PEDIGREE

      American journal of human genetics
    70. POTKIN SG; BUCHSBAUM MS; JIN Y; TANG C; TELFORD J; FRIEDMAN G; LOTTENBERG S; NAJAFI A; GULASEKARAM B; COSTA J; RICHMOND GH; BUNNEY WE
      CLOZAPINE EFFECTS ON GLUCOSE METABOLIC-RATE IN STRIATUM AND FRONTAL-CORTEX

      The Journal of clinical psychiatry
    71. POTKIN SG; BERA R; GULASEKARAM B; COSTA J; HAYES S; JIN Y; RICHMODN G; CARREON D; SITANGGAN K; BERGER B; TELFORD J; PLON L; PLON H; PARK L; CHANG YJ; OLDROYD J; COOPER TB
      PLASMA CLOZAPINE CONCENTRATIONS PREDICT CLINICAL-RESPONSE IN TREATMENT-RESISTANT SCHIZOPHRENIA

      The Journal of clinical psychiatry
    72. SCHROEDER J; BUCHSBAUM MS; SIEGEL BV; GEIDER FJ; HAIER RJ; LOHR J; WU J; POTKIN SG
      PATTERNS OF CORTICAL ACTIVITY IN SCHIZOPHRENIA

      Psychological medicine
    73. JIN Y; POTKIN SG; WU J; DANG C; SANDMAN C
      SINGLE-TRIAL P50 IN NORMAL AND SCHIZOPHRENIC SUBJECTS

      Biological psychiatry
    74. JIN Y; POTKIN SG; WU J; TJAHJONO L; SANDMAN C
      P50 RESPONSES IN NORMAL SUBJECTS WITH SENSORY OVERLOADING

      Biological psychiatry
    75. BELL KM; POTKIN SG; CARREON D; PLON L
      S-ADENOSYLMETHIONINE PLASMA-LEVELS IN MAJOR DEPRESSION - CHANGES WITHDRUG-TREATMENT

      Acta neurologica Scandinavica
    76. POTKIN SG; BUCHSBAUM M; JIN Y; TELFORD J; GULASEKARAM B; RICHMOND G; COSTA J; SITANGGAN K; MARSHALL J; SWANSON J; BYRD R
      DECREASED FDG PET FOLLOWING CLOZAPINE ASSOCIATED WITH IMPROVED FUNCTION

      Biological psychiatry
    77. JIN Y; CHEN R; WU JC; SANDMAN C; POTKIN SG
      SPONTANEOUS ALPHA-ACTIVITY EFFECTS THE AVERAGED AUDITORY P50

      Biological psychiatry
    78. JIN Y; WU J; SANDMAN C; WU JC; BERA R; RICHMOND G; POTKIN SG
      NEGATIVE SYMPTOMS OF SCHIZOPHRENIA RELATED TO ALPHA AND BETA EEG ACTIVITY

      Biological psychiatry
    79. JIN Y; POTKIN SG; SANDMAN C; CHEN R; BUNNEY WE
      SCHIZOPHRENIC-LIKE P50 GATING ABNORMALITY PRODUCED IN NORMALS

      Biological psychiatry
    80. AKBARIAN S; POTKIN SG; BUNNEY WE; WIGAL SB; HAGMAN JO; JONES EG
      NEURONAL DISTRIBUTION CHANGES IN FRONTAL AND TEMPORAL LOBES OF SCHIZOPHRENICS

      Biological psychiatry
    81. POTKIN SG; JINL Y; RINALDI PC; BUCHSBAUM M; BYRD R; MELANDER G; SANDMAN C; HETRIDGE R; YOUNG RF
      THALAMIC MODEL OF SCHIZOPHRENIA - NEUROPSYCHOLOGICAL, EEG AND PET STUDIES

      Biological psychiatry
    82. JIN Y; BERA R; CHEN R; WU JCT; SANDMAN C; WU J; POTKIN SG
      ABNORMAL PHOTIC DRIVING IN SCHIZOPHRENIA - AN IMPROVED FFT METHODOLOGY

      Biological psychiatry
    83. POTKIN SG; BERA R; GULASEKARAM B; JIN Y; COSTA J; GERBER B; RICHMOND G; PLOSZAJ D; CARREON D; COOPER T; SITANGGAN K
      PLASMA CLOZAPINE CONCENTRATIONS ASSOCIATED WITH CLINICAL EFFICACY

      Biological psychiatry
    84. RICHMOND G; POTKIN SG; PLON L; MCELROY T; JIN Y
      ZACOPRIDE, A 5-HT3 RECEPTOR ANTAGONIST, HAS ANTIPSYCHOTIC EFFICACY

      Biological psychiatry
    85. POTKIN SG; ANAND R
      A PARTIAL DOPAMINE AGONIST, SDZ HDC-912, HAS ANTIPSYCHOTIC EFFICACY

      Biological psychiatry
    86. SIEGEL BV; BUCHSBAUM MS; BUNNEY WE; GOTTSCHALK LA; HAIER RJ; LOHR JB; LOTTENBERG S; NAJAFI A; NUECHTERLEIN KH; POTKIN SG; WU JC
      CORTICAL-STRIATAL-THALAMIC CIRCUITS AND BRAIN GLUCOSE METABOLIC-ACTIVITY IN 70 UNMEDICATED MALE-SCHIZOPHRENIC PATIENTS

      The American journal of psychiatry


ASDD Area Sistemi Dipartimentali e Documentali, Università di Bologna, Catalogo delle riviste ed altri periodici
Documento generato il 09/12/19 alle ore 03:43:12